These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1450872)

  • 1. Hormone replacement therapy and cardiovascular disease.
    Meade TW; Berra A
    Br Med Bull; 1992 Apr; 48(2):276-308. PubMed ID: 1450872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy. ESHRE Capri Workshop Group.
    Crosignani PG; La Vecchia C
    Hum Reprod Update; 1999; 5(6):681-7. PubMed ID: 10652978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse neoplastic and cardiovascular outcomes of HRT: the validity of the evidence.
    Shapiro S
    Endocrine; 2004 Aug; 24(3):203-10. PubMed ID: 15542886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Medical Research Council's General Practice Research Framework.
    BMJ; 1996 Feb; 312(7029):473-8. PubMed ID: 8597678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacology of hormone replacement therapy.
    Rosano GM; Panina G
    Drugs Aging; 1999 Sep; 15(3):219-34. PubMed ID: 10503814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
    Chew S; Ng SC
    Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint.
    Lip GY; Beevers G; Zarifis J
    J Intern Med; 1995 Nov; 238(5):389-99. PubMed ID: 7595178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of estrogens and progestogens and cardiovascular risk].
    Boissel JP; Cornu C
    Therapie; 1999; 54(3):387-92. PubMed ID: 10500456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.